Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 510 across all filing types
Latest filing 2023-02-20 Audit Report / Informat…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Jednostkowe Sprawozdanie Finansowe Scope Fluidics S.A.
Audit Report / Information Classification · 1% confidence The document text is a comprehensive financial statement, explicitly titled 'Raport Jednostkowe sprawozdanie finansowe sporządzone na dzień i za rok obrotowy zakończony 31 grudnia 2022 r.' (Individual financial statement prepared as of and for the financial year ended December 31, 2022). It contains a detailed Table of Contents listing the Income Statement ('JEDNOSTKOWE SPRAWOZDANIE Z ZYSKÓW I STRAT'), Statement of Financial Position ('JEDNOSTKOWE SPRAWOZDANIE Z SYTUACJI FINANSOWEJ'), Cash Flow Statement, and Statement of Changes in Equity, along with extensive notes. This structure is characteristic of a full annual financial report, which aligns best with the definition of an Annual Report (10-K), even though the document is in Polish and may not be a formal SEC 10-K filing, it serves the equivalent function of a full yearly financial disclosure. Given the comprehensive nature and the annual period covered (ending Dec 31, 2022), 10-K is the most appropriate classification among the provided options for a full annual report. FY 2022
2023-02-20 Polish
Skonsolidowane Sprawozdanie Finansowe Grupy Kapitałowej Scope Fluudics S.A.
Regulatory Filings Classification · 1% confidence The provided document text consists entirely of XML digital signature blocks ('Signatures') containing cryptographic details (SignedInfo, SignatureValue, KeyInfo, QualifyingProperties). The referenced file name within the signature block is "Oswiadczenie_Zarzadu_dotyczace_sprawozadan_Scope_Fluidics_SA_oraz_Grupy_Kapitalowej_Scope_Fluidics.xhtml". The Polish phrase 'Oświadczenie Zarządu dotyczące sprawozdań' translates to 'Management Board Statement concerning the reports'. This strongly suggests the document is related to the formal submission or certification of official reports, likely the Annual Report (10-K) or an Interim Report (IR), or a specific management certification accompanying them. Since the text provided is only the signature block and not the content of the report itself, and given the context of formal regulatory filings often requiring such signatures, this is most likely an accompanying document or a certification related to the main financial filing. However, without the actual content, and given the nature of the Polish title referring to a 'Management Board Statement concerning reports', it points towards a formal management declaration that often accompanies the primary financial statements. If this were the full report, it would be 10-K or IR. Since it is a signed statement about reports, and it is not a general announcement of publication (RPA/RNS), it is best classified as a component of the formal reporting structure. Given the options, and the reference to 'sprawozdań' (reports), it is most closely related to the comprehensive financial reporting structure. Since the document is extremely short (only signatures) and refers to a statement about reports, it could be interpreted as a regulatory filing (RNS) or a specific management report component. Given the specific nature of the Polish title ('Management Board Statement concerning reports'), it is a formal declaration. In the absence of a specific 'Management Certification' code, and considering it's a formal, signed document related to financial reporting, it falls under the umbrella of formal regulatory documentation. However, the content is purely metadata/signature, which often characterizes a filing wrapper or a very short regulatory notice. If we assume this signature block is attached to the actual financial report (which is not provided), we cannot classify it as 10-K or IR. If this *is* the entire document, it's a formal declaration/notice. The closest fit for a formal, signed declaration related to reports, when the main report content is missing, is often categorized as a general Regulatory Filing (RNS) or potentially a Management Report (MDA) if the statement itself is the core content. Given the structure is purely XML signature data, RNS is the safest fallback for non-standard, signed regulatory components. Revisiting the definitions: 'MDA' is 'Management's detailed explanation of financial results, business trends, and outlook.' A 'Management Board Statement concerning reports' fits this description better than a generic RNS, as it is a specific management commentary. However, the document length is very short (26,921 chars total, truncated text provided), and the content is *only* signatures. This strongly suggests it is an attachment or a wrapper for a larger document, making RPA or RNS more likely based on the 'MENU VS MEAL' rule if the actual report isn't present. Since it's a signed statement about reports, and not just an announcement of publication, I will lean towards the specific management commentary (MDA) as the intent, assuming the actual statement content is implied or truncated, but the signature structure itself is highly specific. Given the ambiguity and the presence of Polish regulatory language, I will classify it as a Regulatory Filing (RNS) as the safest catch-all for a document that is clearly regulatory but doesn't match the full report types (10-K/IR) or the specific MDA/ER definitions based on the provided snippet. Final check: The content is a digital signature block for a document named 'Management Board Statement concerning reports'. This is a formal declaration. If it were the full statement, MDA would fit. If it's just the signature wrapper, RNS is appropriate. I will choose MDA as the intent seems to be capturing the management commentary aspect.
2023-02-20 Polish
Skonsolidowane Sprawozdanie Finansowe Grupy Kapitałowej Scope Fluudics S.A.
Regulatory Filings Classification · 1% confidence The provided document text consists entirely of XML Digital Signature blocks (specifically XAdES signatures) referencing a ZIP file named 'scp_2022-12-31_pl.zip'. This structure indicates that the document itself is not the primary financial report (like a 10-K or IR), but rather a container or metadata file used for verifying the authenticity and integrity of an attached or referenced file. The presence of multiple digital signatures suggests a formal submission process. Since the content is purely metadata/signature information and does not contain the actual financial narrative or tables, it is best classified as a general Regulatory Filing (RNS) or potentially a placeholder/wrapper for a larger filing. Given the context of corporate filings, this XML structure often accompanies a primary submission, but in isolation, RNS is the most appropriate fallback for non-standard, technical regulatory artifacts.
2023-02-20 Polish
Skonsolidowane Sprawozdanie Finansowe Grupy Kapitałowej Scope Fluudics S.A.
Annual Report (ESEF) Classification · 0% confidence FY 2022
2023-02-20 Polish
Zmiana terminu publikacji raportu rocznego - Content (PL)
Report Publication Announcement Classification · 1% confidence The document text is very short (388 characters) and explicitly refers to a previously announced schedule for publishing periodic reports ('raportów okresowych'). It states that the annual report ('raport roczny') for 2022 will be published on a specific date (February 20, 2023), correcting a previous date. This is not the annual report itself (10-K) or the earnings release (ER), but rather an announcement about the timing and publication schedule of future reports. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2023-02-16 Polish
Harmonogram publikacji raportów okresowych w 2023 roku - Content (PL)
Report Publication Announcement Classification · 1% confidence The document text, written in Polish, outlines the planned schedule for the release of various periodic financial reports (annual report, Q1, H1, Q3 reports) for the year 2023. It specifically mentions the dates when these reports will be delivered and references regulatory requirements ('rozporządzenia w sprawie informacji bieżących i okresowych'). Since the document is not the report itself but an announcement detailing *when* the reports will be published, it fits the definition of a Report Publication Announcement (RPA). The document length is very short (1093 chars), further supporting the 'announcement' classification over the actual report classification (like 10-K or IR).
2023-01-31 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.